NextCure Inc (NXTC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE, MD 20705

NextCure, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing next generation immunomedicines for cancer and other diseases. NextCure serves health care industry.

Data as of 2020-08-09
Market Cap263.204 Million Shares Outstanding27.517 Million Avg 30-day Volume1.292 Million
P/E Ratio Dividend Yield EPS-0.99
Price/Sales10.136 Price cash flow ratio8475.7 Price free cash flow ratio-8.4
Book Value12.06 Price to Tangible Book0.79 Alpha0.03
Short Interest Ratio % Short Interest to Float R-squared0.008357
BETA-0.586177 52-week High/Low109.0 / 8.0 Stddev0.381111
View SEC Filings from NXTC instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 81 29 (1.9%)
Aggregate 13F shares on 03/31/2020: 20.195 Million 13.098 Million
Aggregate 13F shares on 12/31/2019: 20.1 Million 13.356 Million
Percent change: 0.47% -1.93%
Funds creating new positions: 10 3
Funds Adding to an existing position: 29 10
Funds closing out their position: 14 7
Funds reducing their position: 25 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NXTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NXTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

27.2 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KABAKOFF DAVID S

  • Director
1,133,577 2020-08-10 1

KHUONG CHAU QUANG

  • Director
232,214 2020-08-07 1

WEBSTER STEPHEN W

  • Director
25,500 2020-07-29 1

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
968,365 2020-07-20 0

HELLER KEVIN N. CHIEF MEDICAL OFFICER

  • Officer
49,011 2020-07-14 2

MORRISON BRIGGS

  • Director
4,800 2020-06-23 1

RICHMAN MICHAEL

0 2020-06-23 1

LI JUDITH

  • Director
0 2020-06-18 1

JONES ELAINE V

  • Director
0 2020-06-18 1

SHANNON TIMOTHY M

  • Director
4,569,100 2020-06-17 0

NICHOLSON GARRY A

  • Director
0 2020-06-15 2

XU STELLA

  • Director
0 2020-06-11 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • Director
  • 10% Owner
2,765,717 2020-04-24 0

MAYER TIMOTHY CHIEF OPERATING OFFICER

  • Officer
0 2020-02-28 1

LANGERMANN SOL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-28 1

LIU LINDA SVP, RESEARCH

  • Officer
0 2020-02-28 2

COBOURN STEVEN P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-28 1

BINGHAM JAMES B. CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-02-28 1

CANAAN X L.P.

CANAAN PARTNERS X LLC

  • Director
  • 10% Owner
0 2020-01-21 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

MEHRA ANAND

POWELL MICHAEL

  • 10% Owner
2,671,856 2019-11-15 1

XU STELLA

QUAN VENTURE FUND II, L.P.

  • Director
  • 10% Owner
0 2019-05-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HELLER KEVIN N. - Officer CHIEF MEDICAL OFFICER

2020-07-14 M 27,229 $1.77 a 49,011 49,011.00 direct

HELLER KEVIN N. - Officer CHIEF MEDICAL OFFICER

2020-07-14 M 27,229 d 38,119 49,011.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments